Phase I Dose-Escalation Study of JNJ-42756493, an Oral Pan-Fibroblast Growth Factor Receptor Inhibitor, in Patients With Advanced Solid Tumors (Q44846770)
Jump to navigation
Jump to search
scientific article published on 31 August 2015
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Phase I Dose-Escalation Study of JNJ-42756493, an Oral Pan-Fibroblast Growth Factor Receptor Inhibitor, in Patients With Advanced Solid Tumors |
scientific article published on 31 August 2015 |
Statements
1 reference
Phase I Dose-Escalation Study of JNJ-42756493, an Oral Pan-Fibroblast Growth Factor Receptor Inhibitor, in Patients With Advanced Solid Tumors (English)
1 reference
1 reference
1 reference
Rastislav Bahleda
1 reference
Rodrigo Dienstmann
1 reference
Jeffrey R Infante
1 reference
Alain Mita
1 reference
Antoine Italiano
1 reference
Emiliano Calvo
1 reference
Barbara Adamo
1 reference
Anas Gazzah
1 reference
Bob Zhong
1 reference
Suso J Platero
1 reference
Johan W Smit
1 reference
Kim Stuyckens
1 reference
Moitreyee Chatterjee-Kishore
1 reference
Jordi Rodon
1 reference
Vijay Peddareddigari
1 reference
Feng R Luo
1 reference
31 August 2015
1 reference
1 reference
33
1 reference
30
1 reference
3401-3408
1 reference
Identifiers
1 reference
1 reference